K9 Biotech

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
K9 Biotech is a ‘one health’ venture treating similar cancers initially in companion dogs followed by humans creating 2 value propositions:

A) K9 Biotech has a better indicator of success in human trials (since companion dogs with cancer are a more accurate preclinical efficacy model).
B) K9 Biotech receives a dual (Veterinary and Human) revenue stream. The former of which can be used to offset the latter’s clindev costs.
Speaker
photo
CEO and Founder
K9 Biotech